in 15 patients ( 10 males , 5 females , 29-62 y ) undergoing 6-methyl-prednisolone-treatment ( 40-80 mg daily ) for various clinical reasons and in 5 healthy volunteers ( 4 male , 1 female , 28-37 y ) receiving 500 mg 6-methyl-prednisolone daily for 3 days plasma- and serum-thromboxane b2 ( txb2 ) , as well as bicyclo-prostaglandin e2 ( bicyclo-pge2 ) were monitored over 3 weeks .
C0032105
plasma
C0229671
serum